Jeff Arquiette

Jeff Arquiette has extensive work experience in the healthcare industry. Jeff most recently worked as the Clean Room Operations Director at Soleo Health starting in November 2023. Prior to that, they served as the Vice President of Clinical Pharmacy Services at Optum Infusion Services from April 2021 to June 2023.

From January 2018 to April 2021, Jeff held the position of National Director of Pharmacy - West at BriovaRx Infusion Services INC. In this role, they had oversight of pharmacy operations for the West and Midwest regions and was responsible for sterile compounding.

Before that, Jeff worked at BriovaRx Infusion Services, Inc. as the Operations Performance Manager from January 2016 to January 2018. Jeff also worked at AXELACARE HEALTH SOLUTIONS, LLC as the Operations Performance Manager from March 2015 to January 2018, where they had oversight of cleanroom certifications and performed USP 800 gap analysis.

Jeff's earlier experience includes serving as the Interim General Manager at G from June 2015 to December 2015, where they improved operational issues in a home infusion business. Jeff also worked as the General Manager at Owens Healthcare, Infusion Services from March 2014 to January 2015, managing all aspects of the infusion business and improving operating efficiencies.

Jeff's career began at Critical Care Systems in 1992, where they served as the General Manager until 2013. In this role, they oversaw sales, marketing, operations, and business development. Jeff also provided consultation to the Clinical Services Department and was involved in policy review, computer testing, and staff education.

Jeff Arquiette attended Oregon State University from 1978 to 1980, where they obtained a Bachelor of Science degree in Pharmacy. Jeff also holds a Board Certified Sterile Compounding Pharmacist certification from the BPS - Board of Pharmacy Specialties, obtained in December 2019. In addition, they have an Oregon Pharmacy License with the number 6961, obtained from the Oregon Board of Pharmacy.